The clinical role of platelet glycoprotein IIb/IIIa receptor inhibitors in ischemic heart disease.
Where this comes from
- Record sourced from PubMed, PMID 8665658.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The platelet glycoprotein (GP) IIb/IIIa receptor antagonists are powerful new antiplatelet drugs that show promise in reducing complications of coronary angioplasty and acute coronary syndromes.